Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Smith

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2024
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated MelanomaAlaa Embaby, Sanne C F A Huijberts, Liqin Wang, et al.
British Journal of Cancer|June 23, 2022
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)Grant D Stewart, Sarah J Welsh, Stephan Ursprung, et al.
Genome Medicine|March 1, 2020
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumorsChristopher G Smith, Tina Moser, Florent Mouliere, et al.
Science Translational Medicine|June 20, 2020
ctDNA monitoring using patient-specific sequencing and integration of variant readsJonathan C M Wan, Katrin Heider, Davina Gale, et al.
Scientific Reports|August 4, 2015
Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancerNada A Al-Tassan, Nicola Whiffin, Fay J Hosking, et al.
Scientific Reports|May 21, 2015
A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancerNada A Al-Tassan, Nicola Whiffin, Fay J Hosking, et al.
Science Translational Medicine|November 9, 2018
Enhanced detection of circulating tumor DNA by fragment size analysisFlorent Mouliere, Dineika Chandrananda, Anna M Piskorz, et al.
Nature Genetics|October 26, 2010
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33Richard S Houlston, Jeremy Cheadle, Sara E Dobbins, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2017
Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysisSebastian May-Wilson, Amit Sud, Philip J Law, et al.
British Journal of Cancer|June 24, 2016
Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancerDavid Jarvis, Jonathan S Mitchell, Philip J Law, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2024
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated MelanomaAlaa Embaby, Sanne C F A Huijberts, Liqin Wang, et al.
British Journal of Cancer|June 23, 2022
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)Grant D Stewart, Sarah J Welsh, Stephan Ursprung, et al.
Genome Medicine|March 1, 2020
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumorsChristopher G Smith, Tina Moser, Florent Mouliere, et al.
Science Translational Medicine|June 20, 2020
ctDNA monitoring using patient-specific sequencing and integration of variant readsJonathan C M Wan, Katrin Heider, Davina Gale, et al.
Scientific Reports|August 4, 2015
Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancerNada A Al-Tassan, Nicola Whiffin, Fay J Hosking, et al.
Scientific Reports|May 21, 2015
A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancerNada A Al-Tassan, Nicola Whiffin, Fay J Hosking, et al.
Science Translational Medicine|November 9, 2018
Enhanced detection of circulating tumor DNA by fragment size analysisFlorent Mouliere, Dineika Chandrananda, Anna M Piskorz, et al.
Nature Genetics|October 26, 2010
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33Richard S Houlston, Jeremy Cheadle, Sara E Dobbins, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2017
Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysisSebastian May-Wilson, Amit Sud, Philip J Law, et al.
British Journal of Cancer|June 24, 2016
Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancerDavid Jarvis, Jonathan S Mitchell, Philip J Law, et al.
Pageof 5